Study | Year | Nb | Location | Age (years) | Gender | Cliencal symptoms | History (months) | Peripheral blood abnormalities | Maximum diameter (mm) | T1-weight | T2-weight | Enhancement | CT | Edema* | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wang,Y.B., et al. [25] | 2018 | 1 | 1 | Left frontal lobe | 51 | F | Left frontal scalp swelling | 12 | NA | 35 | Hypointense | Hyperintense | Yes | NA | NA |
Yongjun, L., et al. [6] | 2015 | 9 | 1 | Right frontal lobe | 39 | F | Headache, dizziness, and vomiting(8/9) | NA | Anemia(4/9) | NA | Hypointense (9/9) | Hyperintense(7/9) | Yes(9/9) | Hyperdense(6/6) | Yes(5/6) |
2 | Right lateral lobe | 30 | M | Epilepsy(3/9) | Â | Â | Â | Â | Hypointense (2/9) | Â | Â | Â | |||
3 | Occipital sagittal sinus side | 52 | M | Vision loss(2/9) | Â | Â | Â | Â | Â | Â | Â | Â | |||
4 | Cerebellopontine angle | 63 | F | Hearing loss(1/9) | Â | Â | Â | Â | Â | Â | Â | Â | |||
5 | Cerebral falx | 9 | F | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||
6 | Sphenoid ridge | 47 | M | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||
7 | Right occiput | 34 | M | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||
8 | Left forehead | 59 | M | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||
9 | Left frontal temporalis lobe | 54 | F | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||
Tao, X., et al. [11] (multicenter study without individual information) | 2017 | 56 | 56 | Frontal convexity (19) | 44.6 ± 12 | F(28/56) | Headache or increased intracranial hypertension (24/56) | Average 2 | NA | 46 ± 16.7 | Isointense (34/55) | Isointense (25/55) | Homogeneous enhancement (39/55) | Isodense (11/25) | - (13/56) |
 |  |  | Parietal convexity (10) |  | M(28/56) | Limb weakness (8/56) |  |  |  | Hypointense (21/55) | Hypointense (5/55) | Heterogeneous enhancement (16/55) | Hyperintense (10/25) |  + (21/56) | |
 |  |  | Lateral ventricle (3) |  |  | Dizziness(7/56) |  |  |  |  | Hyperintense (25/55) |  | Mixed density (4/25) |  +  + (8/56) | |
 |  |  | Pineal region(2) |  |  | Blurred vision (7/56) |  |  |  |  |  |  |  |  +  +  + (14/56) | |
 |  |  | Posterior fossa convexity (1) |  |  | Numbness (6/56) |  |  |  |  |  |  |  |  | |
 |  |  | Fourth ventricle(1) |  |  | Seizures (6/56) |  |  |  |  |  |  |  |  | |
 |  |  | Sphenoid ridge(6) |  |  | Memory loss (3/56) |  |  |  |  |  |  |  |  | |
 |  |  | Tuberculum sellae/Parasellar (5) |  |  | Diplopia(3/56) |  |  |  |  |  |  |  |  | |
 |  |  | Cerebellopontine angle (3) |  |  | Facial paralysis (3/56) |  |  |  |  |  |  |  |  | |
 |  |  | Petroclival region (3) |  |  | Hearing loss(2/56) |  |  |  |  |  |  |  |  | |
 |  |  | Foramen magnum (2) |  |  | Hyposmia (3/56) |  |  |  |  |  |  |  |  | |
 |  |  | Anterior skull base (1) |  |  | Asymptomatic(7/56) |  |  |  |  |  |  |  |  | |
de Almeida, G.B. and G. Januário [26] | 2022 | 1 | 1 | Bilateral frontoparietal lobe | 57 | F | Left hemiparesis | NA | Normal | 70 | Isointense | Hypointense | Homogeneous enhancement | Hyperdense | Yes |
Wang, H., et al. [7] | 2021 | 1 | 1 | Skull base to C6 | 44 | M | Complaints of limb weakness | NA | Anemia | NA | Isointense | Isointense | Homogeneous enhancement | NA | NA |
Gu, K.C., et al. [27] | 2020 | 1 | 1 | Right frontal lobe | 36 | M | Headache | NA | Normal | 40 | Hyperintense | Hypointense | Yes | Mixed density | Yes |
Study | Year | Nb | Location | Age (years) | Gender | Cliencal symptoms | History (months) | Peripheral blood abnormalities | Maximum diameter (mm) | TIW1 | T2W2 | Enhancement | CT | Edema | |
Li, J., et al. [28] | 2021 | 1 | 1 | Skull base, tentorium, sella area, and C1-6 | 44 | M | Extremities weakness | 2 | NA | NA | Isointense | Isointense | Homogeneous enhancement | NA | NA |
Wang, Y.B., et al. [4] | 2014 | 1 | 1 | Ventricle | 37 | F | Generalized tonic–clonic seizure | 5 Hours | NA | 40 | Hypointense | Hyperintense | Yes | NA | Yes |
Kanno, H., et al. [15] | 2011 | 1 | 1 | Right jugular foramen | 55 | F | Hoarseness and dysphasia | NA | NA | 15 | Isointense | Hyperintense | Yes | Mixed density, homogeneous enhancement | NA |
Yang, X., et al. [29] | 2018 | 1 | 1 | Lateral ventricle | 47 | F | Occipital-cervical region pain | 6 | NA | NA | Isointense | Hyperintense | Yes | NA | NA |
Avninder, S., V. Gupta, and K.C. Sharma [30] | 2008 | 1 | 1 | The medulla and upper cervical cord mass | 22 | F | Headache | 6 | NA | 35 | Isointense | NA | Homogeneous enhancement | NA | NA |
Majumdar, K., et al. [31] | 2013 | 1 | 1 | Right sphenoid rigid | 50 | M | Blurred vision | NA | Normal | 50 | NA | Hyperintense | Yes | NA | NA |
Zhu, H.D., et al. [8] | 2013 | 19 | 1 | Left occipital lobe | 20 | F | NA | NA | Normal |  | NA | NA | Homogeneous enhancement (11/14) |  |  +  |
 |  | 2 | Right frontoparietal lobe | 28 | F |  |  | Hyperglobulinemia/Anemia |  |  |  | Heterogeneous enhancement (3/14) |  |  +  +  +  | |
 |  | 3 | Left temporal lobe | 42 | M |  |  | Normal |  |  |  |  |  | - | |
 |  | 4 | Left frontotemporal lobe | 48 | F |  |  | Normal |  |  |  |  |  | NA | |
 |  | 5 | Right frontal falx | 77 | M |  |  | Normal |  |  |  |  |  | - | |
 |  | 6 | Right frontal lobe | 46 | M |  |  | Normal |  |  |  |  |  |  +  | |
 |  | 7 | Left occipital lobe | 46 | M |  |  | Normal |  |  |  |  |  | - | |
 |  | 8 | Right frontoparietal lobe | 57 | M |  |  | Normal |  |  |  |  |  |  +  | |
 |  | 9 | Left sphenoid ridge | 58 | F |  |  | Normal |  |  |  |  |  |  +  +  | |
 |  | 10 | Right frontal falx | 79 | M |  |  | Normal |  |  |  |  |  | - | |
 |  | 11 | Right frontal falx | 63 | F |  |  | Normal |  |  |  |  |  |  +  | |
 |  | 12 | Right frontal falx | 71 | M |  |  | Normal |  |  |  |  |  |  +  +  | |
 |  | 13 | Right frontal lobe | 46 | F |  |  | Normal |  |  |  |  |  |  +  +  | |
 |  | 14 | C1-2 | 25 | M |  |  | Anemia |  |  |  |  |  | - | |
 |  | 15 | Foramen magnum to C1-4 | 57 | F |  |  | Normal |  |  |  |  |  | - | |
 |  | 16 | Left cerebellum &tentorium | 21 | F |  |  | Anemia |  |  |  |  |  | - | |
 |  | 17 | Right frontoparietal lobe | 40 | F |  |  | Normal |  |  |  |  |  |  +  | |
 |  | 18 | C3-4 | 51 | M |  |  | Normal |  |  |  |  |  | - | |
 |  | 19 | Left frontoparietal lobe | 24 | F |  |  | Normal |  |  |  |  |  |  +  +  +  | |
Fukui, K., et al. [32] | 2021 | 1 | 1 | C2-3 | 43 | M | Neck pain | 12 | Hyperglobulinemia/Anemia | Â | Isointense | Hyperintense | Homogeneous enhancement | Â | NA |